Q

Quanterix Corp
D

QTRX

14.040
USD
-0.71
(-4.81%)
مغلق
حجم التداول
13,690
الربح لكل سهم
0
العائد الربحي
0
P/E
-13
حجم السوق
514,662,833
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABUS
    0.03500
    (0.93%)
    3.80500 USD
    A
    ALLO
    -0.21500
    (-7.29%)
    2.73500 USD
    B
    BEAM
    -1.310
    (-4.14%)
    30.330 USD
    C
    CRSP
    -2.450
    (-4.28%)
    54.840 USD
    E
    EDIT
    -0.28500
    (-5.26%)
    5.13500 USD
    G
    GH
    -1.770
    (-5.04%)
    33.380 USD
    MRNA
    -25.020
    (-20.99%)
    94.160 USD
    REGN
    13.14
    (1.22%)
    1,091.19 USD
    R
    RPTX
    -0.33000
    (-8.82%)
    3.41000 USD
    V
    VYGR
    -0.59000
    (-6.37%)
    8.67000 USD
الأخبار
المقالات

العنوان: Quanterix Corp

القطاع: Healthcare
الصناعة: Medical Devices
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.